Table of Contents Author Guidelines Submit a Manuscript
Journal of Chemistry
Volume 2013, Article ID 804683, 11 pages
http://dx.doi.org/10.1155/2013/804683
Research Article

Synthesis, Characterization, and Crystal Structures of Bis-Imidazolium Salts and Respective Dinuclear Ag(I) N-Heterocyclic Carbene Complexes: In Vitro Anticancer Studies against “Human Colon Cancer” and “Breast Cancer”

1The School of Chemical Sciences, Universiti Sains Malaysia (USM), 11800 Penang, Malaysia
2EMAN Research and Testing Laboratory, The School of Pharmaceutical Sciences, Universiti Sains Malaysia (USM), 11800 Penang, Malaysia

Received 10 May 2013; Revised 14 July 2013; Accepted 17 July 2013

Academic Editor: Cristina Femoni

Copyright © 2013 Rosenani A. Haque et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Parkin, F. Bray, J. Ferlay, and P. Pisani, “Global cancer statistics, 2002,” Cancer Journal for Clinicians, vol. 55, no. 2, pp. 74–108, 2005. View at Google Scholar · View at Scopus
  2. J. Weitz, M. Koch, J. Debus, T. Höhler, P. R. Galle, and M. W. Büchler, “Colorectal cancer,” Lancet, vol. 365, no. 9454, pp. 153–165, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. W. Liu and R. Gust, “Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs,” Chemical Society Reviews, vol. 42, no. 2, pp. 755–773, 2013. View at Google Scholar
  4. N. Meyer, E. Schuh, and F. Mohr, “Silver and gold,” Annual Reports on the Progress of Chemistry A, vol. 107, pp. 233–245, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Gautier and F. Cisnetti, “Advances in metal-carbene complexes as potent anti-cancer agents,” Metallomics, vol. 4, no. 1, pp. 23–32, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Mercs and M. Albrecht, “Beyond catalysis: N-heterocyclic carbene complexes as components for medicinal, luminescent, and functional materials applications,” Chemical Society Reviews, vol. 39, no. 6, pp. 1903–1912, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Gasser and N. Metzler-Nolte, “The potential of organometallic complexes in medicinal chemistry,” Current Opinion in Chemical Biology, vol. 16, no. 1-2, pp. 84–91, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. M. L. Teyssot, A. S. Jarrousse, M. Manin et al., “Metal-NHC complexes: a survey of anti-cancer properties,” Dalton Transactions, no. 35, pp. 6894–6902, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Oehninger, R. Rubbiani, and I. Ott, “N-Heterocyclic carbene metal complexes in medicinal chemistry,” Dalton Transactions, vol. 42, pp. 3269–3284, 2013. View at Google Scholar
  10. S. J. Tan, Y. K. Yan, P. P. F. Lee, and K. H. Lim, “Copper, gold and silver compounds as potential new anti-tumor metallodrugs,” Future Medicinal Chemistry, vol. 2, no. 10, pp. 1591–1608, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. I. Ott and R. Gust, “Preclinical and clinical studies on the use of platinum complexes for breast cancer treatment,” Anti-Cancer Agents in Medicinal Chemistry, vol. 7, no. 1, pp. 95–110, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Gasser, I. Ott, and N. Metzler-Nolte, “Organometallic anticancer compounds,” Journal of Medicinal Chemistry, vol. 54, no. 1, pp. 3–25, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. M. J. Hannon, “Metal-based anticancer drugs: from a past anchored in platinum chemistry to a post-genomic future of diverse chemistry and biology,” Pure and Applied Chemistry, vol. 79, no. 12, pp. 2243–2261, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. J. M. Rademaker-Lakhai, D. van den Bongard, D. Pluim, J. H. Beijnen, and J. H. M. Schellens, “A phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent,” Clinical Cancer Research, vol. 10, no. 11, pp. 3717–3727, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. C. G. Hartinger, M. A. Jakupec, S. Zorbas-Seifried et al., “KP1019, a new redox-active anticancer agent—preclinical development and results of a clinical phase I study in tumor patients,” Chemistry and Biodiversity, vol. 5, no. 10, pp. 2140–2155, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Vessières, S. Top, W. Beck, E. Hillard, and G. Jaouen, “Metal complex SERMs (selective oestrogen receptor modulators). The influence of different metal units on breast cancer cell antiproliferative effects,” Dalton Transactions, no. 4, pp. 529–541, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. P. M. Abeysinghe and M. M. Harding, “Antitumour bis(cyclopentadienyl) metal complexes: titanocene and molybdocene dichloride and derivatives,” Dalton Transactions, no. 32, pp. 3474–3482, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Eloy, A. S. Jarrousse, M. L. Teyssot et al., “Anticancer activity of silver-N-heterocyclic carbene complexes: caspase-independent induction of apoptosis via mitochondrial apoptosis-inducing factor (AIF),” ChemMedChem, vol. 7, no. 5, pp. 805–814, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. C. H. Wang, W. C. Shih, H. C. Chang et al., “Preparation and characterization of amino-linked heterocyclic carbene palladium, gold, and silver complexes and their use as anticancer agents that act by triggering apoptotic cell death,” Journal of Medicinal Chemistry, vol. 54, no. 14, pp. 5245–5249, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Haque, M. Iqbal, P. Asekunowo et al., “Synthesis, structure, anticancer, and antioxidant activity of para-xylyl linked bis-benzimidazolium salts and respective dinuclear Ag(I) N-heterocyclic carbene complexes (Part-II),” Medicinal Chemistry Research, 2013. View at Publisher · View at Google Scholar
  21. R. A. Haque, S. Budagumpi, S. Y. Choo, M. K. Choong, B. E. Lokesh, and K. Sudesh, “Nitrile-functionalized Hg(II)- and Ag(I)-N-heterocyclic carbene complexes: synthesis, crystal structures, nuclease and DNA binding activities,” Applied Organometallic Chemistry, vol. 26, no. 12, pp. 689–700, 2012. View at Google Scholar
  22. R. A. Haque, M. Z. Ghdhayeb, A. W. Salman, S. Budagumpi, M. B. Khadeer Ahamed, and A. M. S. Abdul Majid, “Ag(I)-N-heterocyclic carbene complexes of N-allyl substituted imidazol-2-ylidenes with ortho-, meta- and para-xylyl spacers: synthesis, crystal structures and in vitro anticancer studies,” Inorganic Chemistry Communications, vol. 22, pp. 113–119, 2012. View at Publisher · View at Google Scholar
  23. R. A. Haque, M. A. Iqbal, S. Budagumpi et al., “Binuclear meta-xylyl-linked Ad(I)-N-heterocyclic carbene complexes of N-alkyl/aryl-alkyl-substituted bis-benzimidazolium salts: synthesis, crystal structures and in vitro anticancer studies,” Applied Organometallic Chemistry, vol. 27, no. 4, pp. 214–223, 2013. View at Google Scholar
  24. M. A. Iqbal, R. A. Haque, S. F. Nasri et al., “Potential of silver against human colon cancer: (synthesis, characterization and crystal structures of xylyl (Ortho, meta, & Para) linked bis-benzimidazolium salts and Ag(I)-NHC complexes: in vitro anticancer studies),” Chemistry Central Journal, vol. 7, no. 1, article 27, 2013. View at Publisher · View at Google Scholar
  25. M. A. Iqbal, R. A. Haque, M. B. K. Ahamed, Abdul, M. A. M. S, and S. Al-Rawi, “Synthesis and anticancer activity of para-xylyl linked bis-benzimidazolium salts and respective Ag(I) N-heterocyclic carbene complexes,” Medicinal Chemistry Research, vol. 22, no. 5, pp. 2455–2466, 2013. View at Google Scholar
  26. C. Graham, “The role of silver in wound healing,” British Journal of Nursing, vol. 14, no. 19, pp. S22–S24, 2005. View at Google Scholar · View at Scopus
  27. J. C. Garrison and W. J. Youngs, “Ag(I) N-heterocyclic carbene complexes: synthesis, structure, and application,” Chemical Reviews, vol. 105, no. 11, pp. 3978–4008, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Shukla and A. P. Mishra, “Synthesis, structure, and anticancerous properties of silver complexes,” Journal of Chemistry, vol. 2013, Article ID 527123, 6 pages, 2013. View at Publisher · View at Google Scholar
  29. A. Melaiye, R. S. Simons, A. Milsted et al., “Formation of water-soluble pincer silver(I)-carbene complexes: a novel antimicrobial agent,” Journal of Medicinal Chemistry, vol. 47, no. 4, pp. 973–977, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Hackenberg, A. Deally, G. Lally et al., “Novel nonsymmetrically p-benzyl-substituted (benz)imidazole N-heterocyclic carbene-silver(I) acetate complexes: synthesis and biological evaluation,” International Journal of Inorganic Chemistry, vol. 2012, Article ID 121540, 13 pages, 2012. View at Publisher · View at Google Scholar
  31. G. Merino, J. W. Jonker, E. Wagenaar et al., “Transport of anthelmintic benzimidazole drugs by breast cancer resistance protein (BCRP/ABCG2),” Drug Metabolism and Disposition, vol. 33, no. 5, pp. 614–618, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Narasimhan, D. Sharma, and P. Kumar, “Benzimidazole: a medicinally important heterocyclic moiety,” Medicinal Chemistry Research, vol. 21, no. 3, pp. 269–283, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Bielawski, S. Wołczyński, and A. Bielawska, “Inhibition of DNA topoisomerase I and II, and growth inhibition of MDA-MB-231 human breast cancer cells by bis-benzimidazole derivatives with alkylating moiety,” Polish Journal of Pharmacology, vol. 56, no. 3, pp. 373–378, 2004. View at Google Scholar · View at Scopus
  34. S. Bonham, L. O'Donovan, M. P. Carty, and F. Aldabbagh, “First synthesis of an aziridinyl fused pyrrolo[1,2-a]benzimidazole and toxicity evaluation towards normal and breast cancer cell lines,” Organic and Biomolecular Chemistry, vol. 9, no. 19, pp. 6700–6706, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. F. Cachoux, T. Isarno, M. Wartmann, and K. H. Altmann, “Total synthesis and biological assessment of benzimidazole-based analogues of epothilone A: ambivalent effects on cancer cell growth inhibition,” ChemBioChem, vol. 7, no. 1, pp. 54–57, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. X. Hou, F. Huang, J. M. Carboni et al., “Drug efflux by breast cancer resistance protein is a mechanism of resistance to the benzimidazole insulin-like growth factor receptor/insulin receptor inhibitor, BMS-536924,” Molecular Cancer Therapeutics, vol. 10, no. 1, pp. 117–125, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. B. Narasimhan, D. Sharma, and P. Kumar, “Biological importance of imidazole nucleus in the new millennium,” Medicinal Chemistry Research, vol. 20, no. 8, pp. 1119–1140, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. T. D. Penning, G. D. Zhu, V. B. Gandhi et al., “Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer,” Journal of Medicinal Chemistry, vol. 52, no. 2, pp. 514–523, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. A. M. Youssef, A. Malki, M. H. Badr, R. Y. Elbayaa, and A. S. Sultan, “Synthesis and anticancer activity of novel benzimidazole and benzothiazole derivatives against HepG2 liver cancer cells,” Medicinal Chemistry, vol. 8, no. 2, pp. 151–162, 2012. View at Google Scholar
  40. R. A. Haque and M. A. Iqbal, “Synthesis and characterization of ortho-xylyl linked bis-benzimidazolium salts,” Asian Journal of Chemistry, vol. 24, no. 6, pp. 2625–2628, 2012. View at Google Scholar
  41. R. A. Haque, M. A. Iqbal, S. A. Ahmad, T. S. Chia, and H. K. Fun, “3,3′-[1,4-Phenylenebis(methylene)]-bis(1-propylbenzimidazolium) dichloride dihydrate,” Acta Crystallographica E, vol. 68, no. 3, pp. o845–o846, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. F. E. Hahn, “Heterocyclic Carbenes,” Angewandte Chemie, vol. 45, no. 9, pp. 1348–1352, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. F. E. Hahn and M. C. Jahnke, “Heterocyclic carbenes: synthesis and coordination chemistry,” Angewandte Chemie, vol. 47, no. 17, pp. 3122–3172, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. R. A. Haque, M. Z. Ghdhayeb, S. Budagumpi et al., “Non-symmetrically substituted N-heterocyclic carbene-Ag(I) complexes of benzimidazol-2-ylidenes: synthesis, crystal structures, anticancer activity and transmetallation studies,” Inorganica Chimica Acta, vol. 394, no. 1, pp. 519–525, 2012. View at Google Scholar
  45. S. Ray, R. Mohan, J. K. Singh et al., “Anticancer and antimicrobial metallopharmaceutical agents based on palladium, gold, and silver N-heterocyclic carbene complexes,” Journal of the American Chemical Society, vol. 129, no. 48, pp. 15042–15053, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. W. J. Youngs, A. R. Knapp, P. O. Wagers, and C. A. Tessier, “Nanoparticle encapsulated silver carbene complexes and their antimicrobial and anticancer properties: a perspective,” Dalton Transactions, vol. 41, no. 2, pp. 327–336, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. M. A. Iqbal, R. A. Haque, S. Budagumpi, M. B. Khadeer Ahamed, and A. M. S. Abdul Majid, “Short metal-metal separations and in vitro anticancer studies of a new dinuclear silver(I)-N-heterocyclic carbene complex of para-xylyl-linked bis-benzimidazolium salt,” Inorganic Chemistry Communications, vol. 28, pp. 64–69, 2013. View at Google Scholar
  48. R. A. Haque, S. F. Nasri, and M. A. Iqbal, “A new dinuclear Ag(I)-N-heterocyclic carbene complex derived from para-xylyl linked bis-imidazolium salt: synthesis, crystal structure, and in vitro anticancer studies,” Journal of Coordination Chemistry, vol. 66, no. 5, pp. 2679–2692, 2013. View at Publisher · View at Google Scholar
  49. R. A. Haque and M. A. Iqbal, “Synthesis and characterization of ortho-xylyl linked bis-benzimidazolium salts (Part-II),” Asian Journal of Chemistry, vol. 25, no. 4, pp. 3049–3054, 2012. View at Google Scholar
  50. M. Hranjec, K. Starčević, S. K. Pavelić, P. Lučin, K. Pavelić, and G. Karminski Zamola, “Synthesis, spectroscopic characterization and antiproliferative evaluation in vitro of novel Schiff bases related to benzimidazoles,” European Journal of Medicinal Chemistry, vol. 46, no. 6, pp. 2274–2279, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. R. A. Haque, A. W. Salman, T. S. Guan, and H. H. Abdallah, “New N-heterocyclic carbene mercury(II) complexes: close mercury-arene interaction,” Journal of Organometallic Chemistry, vol. 696, no. 22, pp. 3507–3512, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. M. V. Baker, D. H. Brown, R. A. Haque, B. W. Skelton, and A. H. White, “Dinuclear N-heterocyclic carbene complexes of silver(I), derived from imidazolium-linked cyclophanes,” Dalton Transactions, no. 21, pp. 3756–3764, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. B. Bildstein, M. Malaun, H. Kopacka et al., “N,N′-diferrocenyl-N-heterocyclic carbenes and their derivatives,” Organometallics, vol. 18, no. 21, pp. 4325–4336, 1999. View at Google Scholar · View at Scopus
  54. R. A. Haque, S. F. Nasri, M. M. Rosli, and H. K. Fun, “3,3′-Di-n-propyl-1,1′-(1,3-phenyl-ene-dimethyl-ene)di(1H-imidazol-3-ium) bis-(hexa-fluorophosphate),” Acta Crystallographica Section E, vol. 68, part 7, Article ID o2153, 2012. View at Publisher · View at Google Scholar
  55. R. A. Haque, S. F. Nasri, M. Hemamalini, and H. K. Fun, “3,3′-Di-n-propyl-1,1′-[p-phenyl-enebis(methylene)]diimidazolium dibromide,” Acta Crystallographica E, vol. 67, no. 8, Article ID o1931, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. H. M. J. Wang, “Synthesis, structure, and spectroscopic properties of gold(I)-carbene complexes,” Organometallics, vol. 18, no. 7, pp. 1216–1223, 1999. View at Google Scholar · View at Scopus
  57. A. Kascatan-Nebioglu, M. J. Panzner, C. A. Tessier, C. L. Cannon, and W. J. Youngs, “N-Heterocyclic carbene-silver complexes: a new class of antibiotics,” Coordination Chemistry Reviews, vol. 251, no. 5-6, pp. 884–895, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. R. A. Haque, M. A. Iqbal, M. B. Khadeer Ahamed, A. A. Majid, and Z. A. Abdul Hameed, “Design, synthesis and structural studies of meta-xylyl linked bis-benzimidazolium salts: potential anticancer agents against 'human colon cancer',” Chemistry Central Journal, vol. 6, no. 1, article 68, 2012. View at Publisher · View at Google Scholar